Physician profile
Bryan D Uslick
NPI 1902801483
$1,156.78
in general payments reported to CMS, 2019-2025
18 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $76.92 · 2021: $56.37 · 2022: $282 · 2023: $223 · 2024: $164 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.25 | 2019-2025 | Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.45 | 2019-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $146.39 | 2019-2025 | Gattex, Entyvio |
| Gilead Sciences, INC. | $99.11 | 2020-2025 | |
| Allergan, INC. | $52.43 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $49.22 | 2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $44.30 | 2023-2024 | Ocaliva |
| Ferring Pharmaceuticals INC. | $38.08 | 2021-2023 | Cimzia |
| Nestle Healthcare Nutrition INC. | $37.91 | 2022 | |
| Janssen Biotech, INC. | $31.76 | 2022-2024 | Tremfya |
| Genzyme Corporation | $24.45 | 2023 | |
| Pfizer INC. | $23.98 | 2023 | |
| Aimmune Therapeutics, INC. | $22.04 | 2024 | |
| Braintree Laboratories, INC. | $20.71 | 2019 | |
| Shionogi INC | $20.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.12 | 2024 | Pillcam |
| Lilly USA, LLC | $13.11 | 2024 | Omvoh |
| Merck Sharp & Dohme LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Uslick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.